GlassScriptPhysician profile
Elisabeth Curtis
NPI 1700066172
$1,371.89
in general payments reported to CMS, 2019-2025
25 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $76.71 · 2021: $40.79 · 2022: $114 · 2023: $308 · 2024: $298 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $315.94 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $111.73 | 2019-2025 | |
| Organon LLC | $107.02 | 2024-2025 | Jada System |
| Mayne Pharma Commercial LLC | $97.18 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $93.55 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $85.59 | 2019-2025 | Myosure Tissue Removal Device, Fetal Fibronectin Enzyme Immunoassay |
| Optumhealth Care Solutions, LLC | $55.16 | 2023-2025 | Vivify Health Care Team Portal, Vivify Health Care Team Portal 001, Eitan Medical |
| Biogen, INC. | $54.61 | 2024-2025 | Zurzuvae |
| Millicent US INC | $46.14 | 2019-2020 | |
| Abbott Laboratories | $40.67 | 2023-2025 | Proclaim, Freestyle Libre 3 |
| Coopersurgical, INC. | $39.20 | 2025 | Paragard T 380a, Sos |
| Roche Diagnostics Corporation | $37.53 | 2019 | |
| Radius Health, INC. | $36.50 | 2020 | |
| Exeltis, USA INC. | $33.94 | 2022 | |
| Evofem Biosciences, INC. | $31.03 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.46 | 2019 | |
| Baxter Healthcare | $21.80 | 2024 | Perclot |
| Innovation Technologies INC | $21.69 | 2025 | Irrisept |
| Meditrina | $19.59 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $18.76 | 2024 | |
| Genzyme Corporation | $17.13 | 2023 | |
| Exact Sciences Corporation | $16.75 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $16.35 | 2019 | |
| Pfizer INC. | $15.44 | 2023 | |
| Amag Pharmaceuticals, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisabeth Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.